South San Francisco, CA · Founded 2019 · Privately Held (backing)
Operator of an integrated development and manufacturing organization intended for accelerating patients' access to life-saving cell therapies. Cellares is based in South San Francisco, CA and was founded in 2019. It is valued at about $675 million as of Oct 2026, set by institutional fund marks. It has raised $612 million across 1 recorded round; the latest was an $82 million later-stage round in Apr 2021.
PMV mark · valuation
$675.0M
Oct 2026
Priced at
its later-stage round
Aug 2023
Total raised
$612.0M
Last round
Later Stage VC
Apr 2021
Cap table — not yet on record
Cellares's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.